Segall Bryant & Hamill’s SBC Medical Group SBC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$250K Hold
81,307
﹤0.01% 588
2026
Q1
$340K Buy
+81,307
New +$339K ﹤0.01% 568

Other funds holding SBC

Segall Bryant & Hamill's SBC Position: Q2 2026 in Review

Segall Bryant & Hamill held its SBC Medical Group (SBC) position steady in Q2 2026 at 81,307 shares worth $250K. The position accounts for ﹤0.01% of the portfolio, ranked #588.

Segall Bryant & Hamill first reported a position in SBC in Q1 2026 and has held it in 2 quarters since. The position peaked at $340K in Q1 2026. 57 funds tracked by Wall St. Rank hold SBC as of Q2 2026.

  • Segall Bryant & Hamill held 81,307 shares of SBC Medical Group worth $250K as of Q2 2026.
  • Segall Bryant & Hamill left its SBC Medical Group share count unchanged in Q2 2026.
  • SBC Medical Group made up ﹤0.01% of Segall Bryant & Hamill's portfolio in Q2 2026, its #588 holding.
  • Segall Bryant & Hamill first reported a position in SBC Medical Group in Q1 2026 and has held it in 2 quarters since.
  • Segall Bryant & Hamill's SBC Medical Group position peaked at $340K in Q1 2026.
  • 57 funds tracked by Wall St. Rank held SBC Medical Group as of Q2 2026.

Based on Segall Bryant & Hamill's 13F filing for Q2 2026, filed 12 Aug 2026.